M
Marco Salvetti
Researcher at Sapienza University of Rome
Publications - 294
Citations - 13327
Marco Salvetti is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 44, co-authored 263 publications receiving 10931 citations. Previous affiliations of Marco Salvetti include Max Planck Society & Istituto Neurologico Mediterraneo.
Papers
More filters
Journal ArticleDOI
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants
Veronica De Rosa,Mario Galgani,Antonio Porcellini,Alessandra Colamatteo,Marianna Santopaolo,Candida Zuchegna,Antonella Romano,Salvatore De Simone,Claudio Procaccini,Claudia La Rocca,Pietro Biagio Carrieri,Giorgia Teresa Maniscalco,Marco Salvetti,Maria Chiara Buscarinu,Adriana Franzese,Enza Mozzillo,Antonio La Cava,Giuseppe Matarese +17 more
TL;DR: The link between glycolysis and Foxp3-E2 variants via enolase-1 shows a previously unknown mechanism for controlling the induction and function of Treg cells in health and in autoimmunity.
Journal ArticleDOI
B cells and multiple sclerosis.
TL;DR: Findings indicate that substantial numbers of B cells that are infected with Epstein-Barr virus accumulate in these intrameningeal follicles and in white matter lesions and are probably the target of a cytotoxic immune response in MS.
Journal ArticleDOI
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
Jens Kuhle,Giulio Disanto,Ruth Dobson,Rocco Adiutori,Lucia Bianchi,Joanne Topping,Jonathan P. Bestwick,Ute-Christiane Meier,Monica Marta,G. Dalla Costa,Tessel F. Runia,E. P. Evdoshenko,N. Lazareva,Eric Thouvenot,Pietro Iaffaldano,Vita Direnzo,Mohsen Khademi,Fredrik Piehl,Manuel Comabella,Madeleine H. Sombekke,Joep Killestein,Harald Hegen,Scott L. Rauch,Sandra D'Alfonso,José C. Álvarez-Cermeño,P. Kleinova,Dana Horakova,Romy Roesler,Florian Lauda,Sara Llufriu,Timucin Avsar,Ugur Uygunoglu,Ayse Altintas,S. Saip,Til Menge,Cecilia Rajda,Roberto Bergamaschi,N. Moll,Michael Khalil,Romain Marignier,Irena Dujmovic,Henrik Larsson,Clas Malmeström,Elio Scarpini,Chiara Fenoglio,Stig Wergeland,Alice Laroni,Viviana Annibali,Silvia Romano,A.D. Martinez,Adriana Carrá,Marco Salvetti,Antonio Uccelli,Øivind Torkildsen,Kjell-Morten Myhr,Daniela Galimberti,Konrad Rejdak,Jan Lycke,Jette L. Frederiksen,Jelena Drulovic,Christian Confavreux,David Brassat,Christian Enzinger,Siegrid Fuchs,Isabel Bosca,Jean Pelletier,C. Picard,E. Colombo,Diego Franciotta,Tobias Derfuss,Raija L.P. Lindberg,Özgür Yaldizli,László Vécsei,B. C. Kieseier,H.-P. Hartung,Pablo Villoslada,Aksel Siva,Albert Saiz,Hayrettin Tumani,Eva Havrdova,Luisa M. Villar,Maurizio Leone,N. Barizzone,Florian Deisenhammer,Charlotte E. Teunissen,Xavier Montalban,Mar Tintoré,Tomas Olsson,Maria Trojano,Sylvain Lehmann,Giovanni Castelnovo,Sergey V. Lapin,Rogier Q. Hintzen,Ludwig Kappos,Roberto Furlan,Vittorio Martinelli,G. Comi,Sreeram V. Ramagopalan,Gavin Giovannoni +98 more
TL;DR: MRI lesion load, OCB and age at CIS are validated as the strongest independent predictors of conversion to CDMS in this multicentre setting.
Journal ArticleDOI
CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
Viviana Annibali,Giovanni Ristori,Daniela F. Angelini,Barbara Serafini,Rosella Mechelli,Stefania Cannoni,Silvia Romano,Andrea Paolillo,Hadi Abderrahim,Adamo Diamantini,Giovanna Borsellino,Francesca Aloisi,Luca Battistini,Marco Salvetti +13 more
TL;DR: Variations of CD161 expression on CD8(+) T cells identify a subset of lymphocytes with proinflammatory characteristics that have not been previously reported in multiple sclerosis and are likely to contribute to disease immunopathology.
Journal ArticleDOI
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
Sofia Abrahamsson,Daniela F. Angelini,Amy N. Dubinsky,Esther Morel,Unsong Oh,Joanne L. Jones,Daniele Carassiti,Richard Reynolds,Marco Salvetti,Peter A. Calabresi,Alasdair Coles,Luca Battistini,Roland Martin,Richard K. Burt,Paolo A. Muraro +14 more
TL;DR: It is proposed that a favourably modified balance of regulatory and pro-inflammatory lymphocytes underlies the suppression of central nervous system inflammation in patients with multiple sclerosis following non-myeloablative autologous haematopoietic stem cell transplantation with a conditioning regimen consisting of cyclophosphamide and alemtuzumab.